Management of Chronic Noncancer Pain in the Primary Care Setting
- 1 October 2007
- journal article
- review article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 100 (10), 1028-1036
- https://doi.org/10.1097/smj.0b013e3180f626ff
Abstract
While opioids are regarded as the mainstay of chronic pain management, their use is controversial in the minds of many primary care physicians due to clinical concerns about dependence, abuse, and addiction and medicolegal concerns regarding state and federal regulatory authorities. For patients with moderate to moderately severe pain, the treatment of choice is a long-acting opioid or opioid combination drug product to provide sustained analgesia along with improvements in sleep quality, compliance, and possibly quality of life. Careful screening of patients being considered for long-term opioid therapy with validated questionnaires can identify patients who may have difficulties in managing opioids. These patients should not be denied access to opioid therapy, but they do require focused monitoring and case management. Ongoing monitoring should focus on the 4 A's (ie, analgesia, activities of daily living, adverse effects, and aberrant drug-related behaviors), and all aspects of patient care must be thoroughly documented.Keywords
This publication has 31 references indexed in Scilit:
- A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or kneeClinical Therapeutics, 2006
- Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsulesCurrent Medical Research and Opinion, 2006
- Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk ToolPain Medicine, 2005
- Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III TrialPain Medicine, 2005
- Safety, Tolerability, and Effectiveness of Oxymorphone Extended Release for Moderate to Severe Osteoarthritis PainClinical Journal of Sport Medicine, 2005
- Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III studyThe Journal of Pain, 2005
- Validation of a screener and opioid assessment measure for patients with chronic painPain, 2004
- Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic painClinical Therapeutics, 2000
- Drug Abuse, Dependence, and Addiction in Chronic Pain PatientsThe Clinical Journal of Pain, 1992
- Opioid pseudoaddiction — an iatrogenic syndromePain, 1989